Hearing News Watch

Featured image for “Regeneron Successfully Completes Acquisition of Decibel Therapeutics”
Sep. 25, 2023

Regeneron Successfully Completes Acquisition of Decibel Therapeutics

HHTM
TARRYTOWN, NEW YORK — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the successful completion of its acquisition of Decibel Therapeutics, Inc., marking a significant step forward in strengthening the company’s gene therapy and auditory programs. “After several years of successful collaboration, the integration of Decibel’s programs, capabilities and accomplished team will further bolster Regeneron’s genetic medicines portfolio and advance our
Featured image for “Sensorion Reports 2023 First Half Results; Highlights Developments and Progress in Hearing Loss Treatments”
Sep. 21, 2023

Sensorion Reports 2023 First Half Results; Highlights Developments and Progress in Hearing Loss Treatments

HHTM
MONTPELLIER, FRANCE — Sensorion, a biotechnology company dedicated to improving the lives of people with hearing disorders, has recently released its first-half results for 2023, and the reports the outlook for the remainder of the year looks promising. Key Highlights Major Milestones Achieved: Sensorion made significant progress in its mission to develop therapies for hearing loss disorders. One of the
Featured image for “InComm Healthcare Announces Partnership with MDHearing to Offer Hearing Aids as Health Plan Benefits”
Sep. 20, 2023

InComm Healthcare Announces Partnership with MDHearing to Offer Hearing Aids as Health Plan Benefits

HHTM
InComm Payments, a leading payments technology company, has announced a strategic partnership with MDHearing, a direct-to-consumer hearing aid manufacturer, under its InComm Healthcare business unit. This collaboration aims to empower health plan partners to offer supplemental benefit funds to their members for the acquisition of over-the-counter (OTC) hearing aids from MDHearing. These hearing benefits can now be accessed through InComm
Featured image for “Balance Awareness Week Sheds Light on Prevalent Balance Issues Impacting 37 Million U.S. Adults”
Sep. 15, 2023

Balance Awareness Week Sheds Light on Prevalent Balance Issues Impacting 37 Million U.S. Adults

HHTM
ROCKVILLE, MARYLAND – The American Speech-Language-Hearing Association (ASHA) is calling upon the public to expand their understanding of balance disorders as nearly 16% of American adults grapple with these issues. Balance Awareness Week, running from September 17 to September 23, 2023, serves as a pivotal opportunity for individuals to learn about conditions like dizziness, vertigo, and other balance-related challenges. These
Featured image for “William Sawalich Clinches 2023 ARCA Menards Series East Championship Title”
Sep. 15, 2023

William Sawalich Clinches 2023 ARCA Menards Series East Championship Title

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey and SoundGear are thrilled to congratulate William Sawalich for winning the 2023 ARCA Menards Series East championship after earning the victory at Bristol Motor Speedway. Earlier this year, Sawalich signed a multi-year agreement with Joe Gibbs Racing at the age of 16 and has since driven to multiple victories with his No. 18 Toyota Camry during his very first year.  To help raise
Featured image for “Amplifon Earns Recognition in Time Magazine’s Inaugural ‘World’s Best Companies’ List”
Sep. 13, 2023

Amplifon Earns Recognition in Time Magazine’s Inaugural ‘World’s Best Companies’ List

HHTM
MILAN, ITALY –– Time Magazine, in collaboration with market insights firm Statista, has included Amplifon among its list of the best companies in the world. The rankings name 750 of the 10,000 major companies taken into consideration, each with a minimum annual turnover of $100 million and presence on at least two world regions. Amplifon comes under the Engineering, Manufacturing and
Featured image for “Researchers develop clinical staging system to improve treatment approach for meniere’s disease patients”
Sep. 12, 2023

Researchers develop clinical staging system to improve treatment approach for meniere’s disease patients

HHTM
A recent study conducted at Washington University in St. Louis has made significant strides in understanding Meniere’s disease and tailoring treatment approaches to individual patients. Led by Brevin J. Miller and his colleagues, the research aimed to identify the crucial factors influencing treatment responses in Meniere’s disease patients and create a composite clinical severity staging system to aid in more
Featured image for “Cast Your Vote! 2023 Hearing Technology Innovator Awards”
Sep. 11, 2023

Cast Your Vote! 2023 Hearing Technology Innovator Awards

HHTM
Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, today announces the opening of the public voting period for the 4th annual Hearing Technology Innovator Awards™. Through the international awards program, HHTM honors technological innovation and achievement in the hearing industry. Categories and Awards For 2023, the awards will be conferred in
Featured image for “Amplifon’s Enrico Vita Earns Best CEO Award in MedTech from Institutional Investor”
Sep. 07, 2023

Amplifon’s Enrico Vita Earns Best CEO Award in MedTech from Institutional Investor

HHTM
MILAN, ITALY – Enrico Vita, the Chief Executive Officer of Amplifon, a leading player in hearing solutions, has been named “Best CEO” in the European Medical Technology & Services (MedTech) sector by the esteemed Institutional Investor. The accolade comes as part of the annual “All-Developed Europe Executive Team” ranking by Institutional Investor, an independent research institution in the field of
Featured image for “Susan Whichard and Scott Krell Join SafKan Health in Key Leadership Roles”
Sep. 06, 2023

Susan Whichard and Scott Krell Join SafKan Health in Key Leadership Roles

HHTM
SEATTLE, WASHINGTON — SafKan Health, the makers of the FDA-cleared OtoSet® Ear Cleaning System, has announced the appointment of Susan Whichard as Vice President of Commercialization (PT) and Scott Krell as Senior Director of Research & Development. Susan Whichard, in a part-time capacity, will support SafKan Health’s efforts in cultivating strategic relationships. Her role will accelerate clinical research and collaborations